Jan joined Roche Global Medical Affairs in June 2015 and serves as the Therapeutic Area (TA) Head Neuroscience and Rare Diseases in Medical. Jan is very passionate about Medicine and Neuroscience and strongly believes that the possibilities of the biosciences and the digital age will rapidly transform the science and medical practice especially of nervous system disorders and numerous rare diseases. He is strongly inspired by how this will bring better solutions and wellbeing for patient care, the medical community, healthcare ecosystems, and ultimately society as a whole.

Jan is an MD PhD and specialized in psychiatry and neuropharmacology. In the biopharmaceutical industry he held various Clinical Development and Medical Affairs roles and gained longstanding and profound experience in Neuroscience including rare neurological diseases – having worked across many Neurology and Psychiatry disease areas with Novartis, Bristol-Myers Squibb, Johnson & Johnson, Biogen, before joining Roche.

Dr. Cesar Sanz Rodriguez is a medical affairs executive with 19 years of experience in strategic and operational leadership in Medical and Scientific Affairs. Currently, he is Associate Vice President, Head of the Global Medical Affairs organization in MSD’s Mid-Europe region, which includes the midsize and small size countries in Europe. Based in Luzern, Switzerland, he provides leadership for the country and subregional Medical Affairs teams responsible for medical strategy, scientific exchange, congress activity, publication planning, data generation through company-sponsored local studies and investigator-initiated studies, medical information, promotional review and commercial support across different therapy areas. Previously, he held roles of increasing responsibilities at country, regional and global level at MSD from 2001-2014. As such, he gained broad experience across multiple therapy areas, including Oncology, Anti-Infectives, Immunology, Vaccines and Primary Care. Prior to joining MSD, Dr. Sanz Rodriguez was practicing onco-hematology in Madrid, Spain. 

A native from Spain, Dr. Sanz Rodriguez received his medical degree from University of Alcala de Henares and his PhD in Cell Biology from University of Lleida. He then went on to complete a Hematology & Hemotherapy residency at Hospital Universitario de la Princesa in Madrid, Spain. Later on, he completed a Master’s Degree on Statistics Applied to Clinical Research at the Autonomous University of Barcelona and an Executive Program in Management of Health & Pharmaceutical Companies at IE Business School in Madrid.